NM_001127198.5:c.572G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001127198.5(TMC6):​c.572G>A​(p.Gly191Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0695 in 1,598,844 control chromosomes in the GnomAD database, including 4,431 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.092 ( 860 hom., cov: 34)
Exomes 𝑓: 0.067 ( 3571 hom. )

Consequence

TMC6
NM_001127198.5 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -2.62

Publications

22 publications found
Variant links:
Genes affected
TMC6 (HGNC:18021): (transmembrane channel like 6) Epidermodysplasia verruciformis (EV) is an autosomal recessive dermatosis characterized by abnormal susceptibility to human papillomaviruses (HPVs) and a high rate of progression to squamous cell carcinoma on sun-exposed skin. EV is caused by mutations in either of two adjacent genes located on chromosome 17q25.3. Both of these genes encode integral membrane proteins that localize to the endoplasmic reticulum and are predicted to form transmembrane channels. This gene encodes a transmembrane channel-like protein with 10 transmembrane domains and 2 leucine zipper motifs. [provided by RefSeq, Jul 2008]
TMC6 Gene-Disease associations (from GenCC):
  • epidermodysplasia verruciformis, susceptibility to, 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • epidermodysplasia verruciformis
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0011823177).
BP6
Variant 17-78124950-C-T is Benign according to our data. Variant chr17-78124950-C-T is described in ClinVar as Benign. ClinVar VariationId is 1164814.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.17 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TMC6NM_001127198.5 linkc.572G>A p.Gly191Asp missense_variant Exon 7 of 20 ENST00000590602.6 NP_001120670.1 Q7Z403-1A0A024R8V2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TMC6ENST00000590602.6 linkc.572G>A p.Gly191Asp missense_variant Exon 7 of 20 2 NM_001127198.5 ENSP00000465261.1 Q7Z403-1

Frequencies

GnomAD3 genomes
AF:
0.0925
AC:
14074
AN:
152196
Hom.:
857
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.174
Gnomad AMI
AF:
0.0504
Gnomad AMR
AF:
0.0485
Gnomad ASJ
AF:
0.0988
Gnomad EAS
AF:
0.0961
Gnomad SAS
AF:
0.0561
Gnomad FIN
AF:
0.0615
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.0605
Gnomad OTH
AF:
0.0833
GnomAD2 exomes
AF:
0.0657
AC:
14267
AN:
217266
AF XY:
0.0644
show subpopulations
Gnomad AFR exome
AF:
0.178
Gnomad AMR exome
AF:
0.0304
Gnomad ASJ exome
AF:
0.0919
Gnomad EAS exome
AF:
0.0923
Gnomad FIN exome
AF:
0.0592
Gnomad NFE exome
AF:
0.0600
Gnomad OTH exome
AF:
0.0617
GnomAD4 exome
AF:
0.0671
AC:
96994
AN:
1446530
Hom.:
3571
Cov.:
34
AF XY:
0.0660
AC XY:
47465
AN XY:
718814
show subpopulations
African (AFR)
AF:
0.177
AC:
5906
AN:
33288
American (AMR)
AF:
0.0329
AC:
1428
AN:
43366
Ashkenazi Jewish (ASJ)
AF:
0.0942
AC:
2436
AN:
25868
East Asian (EAS)
AF:
0.0850
AC:
3339
AN:
39270
South Asian (SAS)
AF:
0.0540
AC:
4574
AN:
84724
European-Finnish (FIN)
AF:
0.0547
AC:
2610
AN:
47718
Middle Eastern (MID)
AF:
0.0401
AC:
220
AN:
5492
European-Non Finnish (NFE)
AF:
0.0652
AC:
72217
AN:
1107054
Other (OTH)
AF:
0.0714
AC:
4264
AN:
59750
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
5891
11782
17672
23563
29454
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2876
5752
8628
11504
14380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0925
AC:
14082
AN:
152314
Hom.:
860
Cov.:
34
AF XY:
0.0924
AC XY:
6882
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.174
AC:
7219
AN:
41566
American (AMR)
AF:
0.0484
AC:
741
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0988
AC:
343
AN:
3472
East Asian (EAS)
AF:
0.0961
AC:
498
AN:
5180
South Asian (SAS)
AF:
0.0561
AC:
271
AN:
4828
European-Finnish (FIN)
AF:
0.0615
AC:
653
AN:
10622
Middle Eastern (MID)
AF:
0.0646
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
0.0606
AC:
4119
AN:
68022
Other (OTH)
AF:
0.0819
AC:
173
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
659
1317
1976
2634
3293
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
154
308
462
616
770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0707
Hom.:
364
Bravo
AF:
0.0945
TwinsUK
AF:
0.0650
AC:
241
ALSPAC
AF:
0.0672
AC:
259
ESP6500AA
AF:
0.152
AC:
664
ESP6500EA
AF:
0.0613
AC:
524
ExAC
AF:
0.0623
AC:
7481
Asia WGS
AF:
0.0610
AC:
212
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Epidermodysplasia verruciformis Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.69
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
0.58
DANN
Benign
0.86
DEOGEN2
Benign
0.020
T;T;T;.;.
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.098
N
LIST_S2
Benign
0.51
.;.;T;T;T
MetaRNN
Benign
0.0012
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.2
M;M;M;M;.
PhyloP100
-2.6
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.81
.;N;N;N;.
REVEL
Benign
0.032
Sift
Benign
0.71
.;T;T;T;.
Sift4G
Benign
0.23
T;T;T;T;.
Polyphen
0.0080
B;B;B;B;.
Vest4
0.044
MPC
0.21
ClinPred
0.0087
T
GERP RS
-5.2
RBP_binding_hub_radar
1.0
RBP_regulation_power_radar
2.1
Varity_R
0.072
gMVP
0.31
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34712518; hg19: chr17-76121031; COSMIC: COSV59808094; COSMIC: COSV59808094; API